FDA Warning Letter: CGMP Violations in Pharmaceutical Manufacturing | BioBoston Consulting
A recent United States Food and Drug Administration (FDA) warning letter cited a pharmaceutical company for extensive Current Good Manufacturing Practice (cGMP) regulation violations in